GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 97 filers reported holding GOSSAMER BIO INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,236,516 | +188.2% | 6,287,843 | +315.3% | 0.00% | – |
Q2 2023 | $1,817,003 | -50.0% | 1,514,169 | -47.5% | 0.00% | -100.0% |
Q1 2023 | $3,634,743 | +532.6% | 2,884,717 | +989.4% | 0.00% | – |
Q4 2022 | $574,616 | -95.5% | 264,800 | -75.0% | 0.00% | -100.0% |
Q3 2022 | $12,667,000 | -42.2% | 1,057,364 | -59.6% | 0.00% | -50.0% |
Q2 2022 | $21,924,000 | -5.6% | 2,619,249 | -2.1% | 0.01% | +20.0% |
Q1 2022 | $23,224,000 | +7.3% | 2,675,611 | +39.9% | 0.01% | +25.0% |
Q4 2021 | $21,637,000 | +7.2% | 1,913,151 | +19.1% | 0.00% | 0.0% |
Q3 2021 | $20,185,000 | +739.6% | 1,605,851 | +442.3% | 0.00% | – |
Q2 2021 | $2,404,000 | -70.6% | 296,101 | -66.5% | 0.00% | -100.0% |
Q1 2021 | $8,171,000 | +1.7% | 883,396 | +6.3% | 0.00% | 0.0% |
Q4 2020 | $8,035,000 | +488.2% | 830,758 | +654.7% | 0.00% | – |
Q3 2020 | $1,366,000 | +20.5% | 110,072 | +26.1% | 0.00% | – |
Q2 2020 | $1,134,000 | -67.0% | 87,286 | -74.2% | 0.00% | -100.0% |
Q1 2020 | $3,434,000 | +83.0% | 338,352 | +181.7% | 0.00% | – |
Q4 2019 | $1,877,000 | -90.8% | 120,124 | -90.1% | 0.00% | -100.0% |
Q3 2019 | $20,364,000 | -1.0% | 1,212,844 | +30.8% | 0.01% | 0.0% |
Q2 2019 | $20,560,000 | -2.4% | 926,922 | -4.7% | 0.01% | -10.0% |
Q1 2019 | $21,076,000 | – | 972,573 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,164,835 | $27,471,000 | 5.62% |
Kynam Capital Management, LP | 1,832,704 | $15,908,000 | 5.16% |
Octagon Capital Advisors LP | 2,563,138 | $22,248,000 | 4.81% |
Ally Bridge Group (NY) LLC | 450,000 | $3,906,000 | 2.90% |
HHLR ADVISORS, LTD. | 7,420,974 | $64,414,000 | 1.34% |
Palo Alto Investors LP | 1,756,757 | $15,249,000 | 1.18% |
Boxer Capital, LLC | 2,462,358 | $21,373,000 | 1.10% |
Ikarian Capital, LLC | 775,315 | $6,730,000 | 0.88% |
Artal Group S.A. | 2,358,968 | $20,476,000 | 0.86% |
Birchview Capital, LP | 129,088 | $1,120,000 | 0.81% |